Ethema Health Corp (GRST)

[Bubae]

I appreciate the support but stand by to be ridiculed. 😆 I have been talking about this since 2021 and warned about the impending dilution then which crushed shareholders with 1,316,204,675 new shares between March 31st and the end of 2021 taking it into trips for the beginning of 2022.. A few bag holders from that period still show up here and one even calling it a 50/50 proposition. This after Shawn Leon has been talking about the regulation "A" offering and stock consolidation since January in the first podcast. The problem Shawn Leon has is that without serious buy volume from OTC traders he will not get subscribers for the offering. Regulation "A" offerings are exempt from registration and immediately tradable. Those who subscribe will do so at a steep discount to market and work through the their subscription trying to achieve a nice selling average price for their trouble. This means that the regulation "A" offerings typically sell off to below the offering price. Yeah, Lawrence Hawkins cashing out with $1.1 million is absurd given the history. I have been wondering where the cash is really going but that is for another post however.

Bubae
Re: NorfolkIP post# 30172
Friday, May 14, 2021 1:21:30 PM
Post# 30181 of 50122
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=163811739

Judging by all the support level failures they are clearly converting notes. Get your average down and unload when they promote and this runs again in my opinion. They may be growing, but many here will pay for it with their losses which is typical in the OTC. Play it like a pump and dump and you will be happier in the end. All I have seen in recent months despite the endless promotion on this board is more share value destruction by the company and little communication about operations.

For the quarterly period ended March 31, 2021
https://www.sec.gov/Archives/edgar/data/792935/000172186821000319/f2sgrst10q051921.htm
Page 26
The Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued and outstanding 2,262,849,130 and 2,027,085,665 shares of common stock at March 31, 2021 and December 31, 2020, respectively.

For the fiscal year ended: December 31, 2021
https://www.sec.gov/ix?doc=/Archives/edgar/data/0000792935/000190359622000192/sfs10kgrst033022.htm

Page F-28
The Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued and outstanding 3,579,053,805 and 2,027,085,665 shares of common stock at December 31, 2021 and December 31, 2020, respectively.